SYNGENE
Syngene International LtdRelated News - SYNGENE
Syngene International: Co Management Revised Guidance Of Revenue Decline Of 3-5% With Ebitda Margin Of 22-23% -Concall Updates
23 Jan 2026 02:15 PM
Syngene International: Co Expects 2%-3% Decline For FY26 Compared To Previous Mid-Single Digit Growth Prediction.
23 Jan 2026 11:31 AM
SYNGENE INTERNATIONAL: Q3 CONS NET PROFIT 150M RUPEES VS 1.3B (YOY) || Q3 REVENUE 9.17B RUPEES VS 9.4B (YOY)
22 Jan 2026 06:40 PM
SYNGENE INTERNATIONAL: Q3 EBITDA 2.1B RUPEES VS 2.8B (YOY) || Q3 EBITDA MARGIN 22.81% VS 30.05% (YOY)
22 Jan 2026 06:41 PM
SYNGENE INTERNATIONAL: CO HAS EXCEPTIONAL ITEM OF 706M RUPEES || Q3 PBT 990M RUPEES VS 1.8B (YOY)
22 Jan 2026 06:43 PM
SynGene International: Prolongs Research Partnership With Bristol Myers Squibb Through 2035
19 Jan 2026 09:33 AM
Syngene International: Co To Consider Q3 Results On Jan 22
08 Jan 2026 01:45 PM
Syngene International: Co. Wins Court Ruling Regarding Tax Refunds Amounting To ₹48.90 Crores For 2010-11, 2011-12, And 2012-13
31 Dec 2025 07:16 AM
Syngene International: Acquires 8.23% Ownership in O2 Renewable Energy V to Boost Renewable Energy Usage
23 Dec 2025 10:28 PM
Syngene: Reports 77% Drop In CO Exports Month-Over-Month And 53% Decrease YoY
19 Dec 2025 09:53 AM
SynGene: Company Reports 263% Increase in CO Exports Year Over Year
11 Nov 2025 09:26 AM
